Mikkel Bring Christensen

Mikkel Bring Christensen

Clinical Professor

Member of:

  • Clinical Pharmacology


Publication year:
All
11 - 20 out of 118Page size: 10
Sort by: Title
  1. Published

    Cardiovascular effects of high-dose glucagon: a randomised clinical trial

    Petersen, K. M., Bogevig, S., Riis, T., Andersson, N. A. W., Dalhoff, Kim, Holst, Jens Juul, Knop, Filip Krag, Faber, Jens, Petersen, Tonny Studsgaard & Christensen, Mikkel Bring, 2020, In: Diabetologia. 63, SUPPL 1, p. S231-S231

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  2. Published

    Causes of discrepancies between medications listed in the national electronic prescribing system and patients' actual use of medications

    Bülow, Cille, Noergaard, J. D. S. V., Færch, K. U., Pontoppidan, C., Unkerskov, J., Johansson, K. S., Kornholt, J. & Christensen, Mikkel Bring, 2021, In: Basic and Clinical Pharmacology and Toxicology. 129, 3, p. 221-231 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide

    Brønden, A., Knop, Filip Krag & Christensen, Mikkel Bring, 2017, In: Clinical Pharmacokinetics. 56, 7, p. 719-731

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Clinical pharmacology of imeglimin for the treatment of type 2 diabetes

    Johansson, K. S., Brønden, A., Knop, Filip Krag & Christensen, Mikkel Bring, May 2020, In: Expert Opinion on Pharmacotherapy. 21, 8, p. 871-882

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

    Demant, M., Bagger, J. I., Suppli, M. P., Lund, A., Gyldenløve, M., Hansen, K. B., Hare, Kristine Juul, Christensen, Mikkel Bring, Sonne, D. P., Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, Dec 2018, In: Metabolic Syndrome and Related Disorders. 16, 10, p. 530-536 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Diabetes treatment for persons with severe mental illness: A registry-based cohort study to explore medication treatment differences for persons with type 2 diabetes with and without severe mental illness

    Bakkedal, Catrine, Persson, F., Kriegbaum, Margit, Andersen, John Sahl, Christensen, Mikkel Bring, Lind, B., Lykkegaard Andersen, C. & Rozing, M., 2023, In: PLOS ONE. 18, 6, 19 p., e0287017.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Dose-dependent efficacy of the glucose-dependent insulinotropic polypeptide (GIP)receptor antagonistGIP(3-30)NH2 on GIP actions in humans

    Gasbjerg, Lærke Smidt, Bari, E. J., Stensen, S., Hoe, B., Lanng, A. R., Mathiesen, D. S., Christensen, Mikkel Bring, Hartmann, Bolette, Holst, Jens Juul, Rosenkilde, Mette & Knop, Filip Krag, 2021, In: Diabetes, Obesity and Metabolism. 23, 1, p. 68-74

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Drug use in patients with short bowel syndrome and intestinal failure

    Vorre, M. M., Johansson, K. S., Fuglsang, K. A., Horwitz, Henrik, Solem, E. J., Jeppesen, Palle Bekker & Christensen, Mikkel Bring, 2022, In: Danish Medical Journal. 69, 5, A12210940.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Effect of a medicines management model on medication-related readmissions in older patients admitted to a medical acute admission unit-A randomized controlled trial

    Graabaek, T., Hedegaard, U., Christensen, Mikkel Bring, Clemmensen, M. H., Knudsen, T. & Aagaard, L., 2019, In: Journal of Evaluation in Clinical Practice. 25, 1, p. 88-96 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta-analyses-driven approach

    Brønden, Andreas, Christensen, Mikkel Bring, Glintborg, D., Snorgaard, O., Kofoed-Enevoldsen, A., Madsen, G. K., Toft, K., Kristensen, J. K., Højlund, K., Hansen, T. K., Søndergaard, E. & Hansen, K. B., 2023, In: Diabetic Medicine. 40, 8, 12 p., e15157.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 96275756